Veerhealth Care Ltd files SEBI Reg 29(2) disclosure for share acquisition by Ruchi Yogesh Shah & others
On 8 July 2026 the company disclosed a substantial acquisition of its shares by Ruchi Yogesh Shah and associates, as required under SEBI’s takeover regulations.
What Veerhealth Care announced
Veerhealth Care Ltd (BSE: 511523) submitted a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on 8 July 2026. The filing notifies the exchange that Ruchi Yogesh Shah & others have acquired a substantial block of Veerhealth shares, triggering the statutory reporting requirement.
The announcement itself contains no quantitative details – the number of shares, percentage of holding, or consideration paid were not disclosed in the document filed with BSE.
Details of the Regulation 29(2) filing
Regulation 29(2) mandates that any person or group acquiring shares that cross prescribed thresholds (typically 5 % and subsequent 1 % increments) must inform the stock exchange within two trading days. The purpose is to ensure market transparency and give existing shareholders timely information about potential changes in control.
In this case, the filing identifies the acquirer(s) as Ruchi Yogesh Shah & Others. No further information about the identity of the “others”, the exact share count, or the price paid was provided in the PDF linked to the filing.
Key facts at a glance
| Detail | Value |
|---|---|
| Company | Veerhealth Care Ltd |
| BSE ticker | 511523 |
| Filing date | 8 July 2026 |
| Regulation invoked | SEBI (SAST) Regulations, 2011 – Reg 29(2) |
| Acquirer(s) | Ruchi Yogesh Shah & Others |
| Share/transaction details disclosed | No quantitative details disclosed |
| Source | BSE filing (PDF) |
Why this matters for investors
The filing confirms that a significant shareholder group has taken a stake large enough to require regulatory reporting. While the exact size of the holding is unknown, the mere fact of a Reg 29(2) filing signals that the acquirer(s) may be seeking influence over the company’s governance or strategic direction. Investors should monitor subsequent disclosures, such as any offer to purchase additional shares, a formal takeover proposal, or a filing under Regulation 10 (mandatory open offer) if the holding crosses the 25 % threshold.
Because the filing does not disclose dilution‑related figures, there is no immediate impact on the company’s share capital or voting rights that can be quantified at this stage.
Conclusion
Veerhealth Care Ltd has complied with SEBI’s takeover reporting rules by filing a Reg 29(2) notice for a share acquisition by Ruchi Yogesh Shah and associated parties. The filing provides the required transparency but stops short of revealing the scale or financial terms of the transaction. Investors should await any further disclosures that may elaborate on the size of the stake or any subsequent actions by the acquirer(s).
Frequently asked questions
Related stocks
Source filing: view original